BIOA BioAge Labs, Inc.
BioAge Labs, Inc. (BIOA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 100% planned / 0% discretionary
Largest single sale: $4.2M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Barton Shane | Principal Accounting Officer | Sell 10b5-1 | 20,216 | $25.19 | $509.2K | None left | |
| Barton Shane | Principal Accounting Officer | Sell 10b5-1 | 42,350 | $25.21 | $1.1M | None left | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 8,820 | $17.81 | $157.1K | None left | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 7,433 | $20.30 | $150.9K | None left | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 7,433 | $18.75 | $139.4K | None left | |
| Fortney Kristen | Chief Executive Officer | Sell 10b5-1 | 233,107 | $18.12 | $4.2M | 976,949 −19.3% of holding | |
| GOLDSTEIN DOV A MD 4 fills | Chief Financial Officer | Sell 10b5-1 | 27,000 | $19.70 | $531.8K | 40,434 −40% of holding | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 7,433 | $12.85 | $95.5K | None left | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 18,000 | $12.00 | $216.0K | None left | |
| RUBIN PAUL D | Chief Medical Officer | Sell 10b5-1 | 68,897 | $10.19 | $701.9K | None left |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.